heat biologics inc expands product development team to support development of lead product candidates in oncology  heat biologics inc htbx home newsroom news releases heat biologics inc expands product development team to support development of lead product candidates in oncology download pdf durham nc dec   globe newswire  heat biologics inc heat nasdaqhtbx a clinical stage biopharmaceutical company focused on the development of cancer immunotherapies today announced the expansion of its product development team three new directorlevel team members have joined heat to help execute its phase  strategy and prepare for phase  delivery the new hires will assume responsibility for manufacturing regulatory affairs and quality assurance and clinical operations under the direction of dr melissa price vp of clinical and regulatory affairs  our expanded product development team brings us a wealth of relevant expertise said jeff wolf ceo of heat biologics these new team members have broadbased drug development experience that will be very important as we progress our lead products hs‑ and hs through phase  trials for nonsmall cell lung and bladder cancers respectively damien hallet joins heat biologics as senior director of manufacturing and will assume responsibility for overall manufacturing strategy mr hallet has more than  years of international industry experience in the production of multiple biologic medicinal products he has an exceptionally broad scientific and technical background as a scientist and group leader in managing various bioprocess development and manufacturing activities most recently he was cmc project lead at ucb celltech mr hallet holds a master of engineering degree in biochemistry and a master of advanced studies in industrial microbiology from insa de toulouse in france maria oyaski joins heat as director of regulatory affairs and quality assurance and will be responsible for leading the companys regulatory strategy and for assuring quality of manufacturing and clinical operations she brings to the position  years of industry experience with over a decade in regulatory affairs for a broad range of medical products including most recently leading regulatory activities at argos therapeutics for complex cellular immunotherapies in oncology ms oyaski holds regulatory affairs certification rac for both the us and eu she also holds a master of science in cell and molecular biology from the university of pennsylvania and a master of arts in history and philosophy of science from the university of pittsburgh brandon early joins heat as senior director of clinical affairs and will assume overall responsibility for the execution of the companys clinical strategy  mr early brings to heat biologics deep clinical experience in oncology and immunology having led global oncology programs at inc research  mr early began his career as a clinical research coordinator at the university of virginia in the carter immunology center and asthma and allergic disease division  he has published his immunology research in several peerreviewed journals he holds a masters degree in clinical research from the university of virginia  about heat biologics inc  heat biologics inc wwwheatbiocom is a clinicalstage biopharmaceutical company focused on developing its novel offtheshelf impact therapeutic vaccines to combat a wide range of cancers our impact therapy is designed to deliver live geneticallymodified irradiated human cells which are reprogrammed to pump out a broad spectrum of cancerassociated antigens together with a potent immune adjuvant called gp to educate and activate a cancer patients immune system to recognize and kill cancerous cells heat is conducting a phase  trial of its viagenpumatucell hs in patients with nonsmall cell lung cancer as well as a phase  with its vesigenurtacell hs in patients with nonmuscle invasive bladder cancer forward looking statements this press release includes forwardlooking statements on our current expectations and projections about future events in some cases forwardlooking statements can be identified by terminology such as may should potential continue expects anticipates intends plans believes estimates and similar expressions these statements are based upon current beliefs expectations and assumptions and include statements regarding the expected contribution of each of the new team members and the potential for heats impact therapy these statements are subject to a number of risks and uncertainties many of which are difficult to predict including the ability for heats impact therapy to perform as designed and ability to successfully integrate the new team members and the other factors described in our annual report on form k for the year ended december   and our other filings with the sec the information in this release is provided only as of the date of this release and we undertake no obligation to update any forwardlooking statements contained in this release based on new information future events or otherwise except as required by law contact heat biologics inc contact information matthew czajkowski chief financial officer   mattheatbiocom investor relations michael wood lifesci advisors llc    source heat biologics heat biologics inc htbx leading the immunooncology revolution heat’s impact immunotherapy transforms living allogeneic human cancer cells into miniature osmotic pumps that continually secrete cancer antigens to activate a patients own immune system to destroy the cancer cells learn more about our science about us heat biologics is a clinicalstage company focused on developing its proprietary “impact” immune panantigen cytotoxic therapy fully allogeneic “offtheshelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases learn more about heat biologics view our corporate presentation recent news jul   •  am edt heat biologics appoints damien hallet as vice president of cmc development read more jul   •  am edt dr jeff hutchins appointed chief operating officer for heat biologics read more events june    bio international convention learn more june    marcum microcap conference learn more impact therapy a firstinclass fully human cytotoxic t cell specific adjuvant heat biologics’ proprietary impact technology transforms allogenic living cells into miniature osmotic pumps that continually secrete heat shock protein gp the most potent mammalian adjuvant ever described along with its chaperoned antigens view our product pipeline development pipeline sign up for email alerts enter email submit board of directors  heat biologics inc htbx home about heat board of directors jeffrey wolf chairman jeffrey wolf is founder and ceo of heat biologics and cofounder of pelican therapeutics he also founded seedone ventures and served as managing director for the company which was focused on the systematic formation and management of new biomedical companies based upon novel research breakthroughs throughout his career mr wolf has specialized in building lifescience startup organizations and has played an active role in supporting the growth of his companies mr wolfs startups include avigen cofounder and director a nasdaqlisted gene therapy company tyrx pharma cofounder and chairman which was focused on the development of novel biocompatible polymers and recently sold to medtronic elusys therapeutics founder and ceo focused on the development of novel antibodies against infectious diseases and generationone founder and ceo a mobilebased healthcare solutions company mr wolf received his mba from stanford business school his jd from new york university school of law and his ba from the university of chicago where he graduated with honors in economics john monahan phd director dr monahan is currently the chief technology officer of synthetic biologics inc a biotechnology company focused on the development of synthetic dnabased therapeutics and innovative diseasemodifying medicines for serious illnesses dr monahan cofounded avigen inc nasdaqavgn in  a company which has become a leader in its sector for the development of novel pharmaceutical products for the treatment of serious human diseases over a  year period as ceo of avigen he raised over m in several private and public financings including its ipo from  he was vp of rd at somatix therapy corp alameda ca and from  he was director of molecular  cell biology at triton biosciences inc alameda ca prior to that from  he was research group chief department of molecular genetics hoffmannlaroche inc nutley nj and from  to  he was an instructor at baylor college of medicine houston tx he received his phd in biochemistry in  from mcmaster university canada and his bsc from university college dublin ireland in  dr monahan is a board member of tacere therapeutics ca he is also a board member of a number of irish biotech companies including genable cellix luxcel identigen pharmatrin and gk technologies john prendergast phd lead independent director dr prendergast is cofounder of palatin technologies inc a biopharmaceutical company developing targeted receptorspecific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential  dr prendergast has been chairman of the board of palatin since june  and a director since august   dr prendergast is a director and executive chairman of the board of directors of antyra inc a privatelyheld biopharmaceutical firm  he was previously a member of the board of the life science companies avax technologies inc avigen inc and medicinova inc  dr prendergast received his msc and phd from the university of new south wales sydney australia did his postdoctoral fellowship in the department of biochemistry and molecular biology at harvard university and received a css in administration and management from harvard university  edward smith director since january   mr smith has also been managing member of aristar capital management llc a new yorkbased investment firm founded in   from january  until may  mr smith also served as the chief executive officer of agritech worldwide inc “agritech” formerly z trim holdings inc otcpink fber a manufacturer of environmentally friendly agricultural functional ingredients and has been a board member of agritech since    from april  through december  mr smith served as the managing partner of brightline capital management llc “bcm” a new yorkbased investment firm founded in  prior to founding bcm mr smith worked at gracie capital from  gtcr golder rauner from  and credit suisse first boston from  mr smith holds a bachelor of arts in social studies from harvard college and a masters in business administration from harvard business school overview  heat biologics inc htbx home investors overview email alerts tear sheet ir contacts rss news feed overview company profile heat biologics is a clinicalstage company focused on developing its novel offtheshelf impact therapeutic vaccines to combat a wide range of cancers and infectious diseases impact therapy exploits the natural ability of antigens to activate the immune system by utilizing live irradiated offtheshelf genetically modified cells injected into a patient designed to elicit a powerful immune response against the disease target heat’s impact therapy is based upon heat shock protein gp a chaperone protein found in all human cells and normally tethered to our cells with a leash called the kdel sequence impact therapy removes this kdel leash thus transforming allogeneic living cells into powerful miniature osmotic pumps that continually secrete gp and their chaperoned antigens to activate the immune system against the full spectrum of antigens expressed by a patient’s disease heat is currently conducting multiple clinical trials in two indications with its impact therapy based products hs to treat nonmuscle invasive bladder cancer nmibc and hs to treat nonsmall cell lung cancer nsclc corporate presentation view our latest corporate presentation view presentation view press releases recent news jul   •  am edt heat biologics appoints damien hallet as vice president of cmc development jul   •  am edt dr jeff hutchins appointed chief operating officer for heat biologics jun   •  am edt pelican therapeutics a subsidiary of heat biologics receives first tranche of  million cprit grant award stock snapshot htbx nasdaq price change q  quarterly results pdf html earnings release pdf html q filing zip xls html xbrl ir contacts corporate address heat biologics inc  capitola drive durham nc  investor relations melissa m conger t  mcongerheatbiocom transfer agent continental stock transfer  trust company  battery place th floor new york new york  t  email alerts sign up for breaking news sign up compact  heat biologics inc htbx home our science compact compact compact therapy – our next generation platform technology   heat biologics combination panantigen cytotoxic therapy compact therapy enables us to combine a panantigen t cellactivating vaccine and a t cell costimulator in a single product offering the potential benefits of combination immunotherapy without the need for multiple independent biologic products  using compact we have engineered new product candidates that incorporate various ligand fusion proteins targeting costimulatory receptors ox icos bb into the gpig expression vector resulting in a single product candidate that includes both a panantigen t cellpriming vaccine and a t cell costimulator  most recently we have reported preclinical data demonstrating that compact secreting oxl generated the most potent immune response among other compact costimulator variations including tla bbl and icosl as well as compared to systemic delivery of ox agonist antibody and vaccine alone poster video press releases  heat biologics inc htbx home investors press releases email alerts tear sheet ir contacts rss news feed press releases heat biologics inc expands product development team to support development of lead product candidates in oncology download pdf durham nc dec   globe newswire  heat biologics inc heat nasdaqhtbx a clinical stage biopharmaceutical company focused on the development of cancer immunotherapies today announced the expansion of its product development team three new directorlevel team members have joined heat to help execute its phase  strategy and prepare for phase  delivery the new hires will assume responsibility for manufacturing regulatory affairs and quality assurance and clinical operations under the direction of dr melissa price vp of clinical and regulatory affairs  our expanded product development team brings us a wealth of relevant expertise said jeff wolf ceo of heat biologics these new team members have broadbased drug development experience that will be very important as we progress our lead products hs‑ and hs through phase  trials for nonsmall cell lung and bladder cancers respectively damien hallet joins heat biologics as senior director of manufacturing and will assume responsibility for overall manufacturing strategy mr hallet has more than  years of international industry experience in the production of multiple biologic medicinal products he has an exceptionally broad scientific and technical background as a scientist and group leader in managing various bioprocess development and manufacturing activities most recently he was cmc project lead at ucb celltech mr hallet holds a master of engineering degree in biochemistry and a master of advanced studies in industrial microbiology from insa de toulouse in france maria oyaski joins heat as director of regulatory affairs and quality assurance and will be responsible for leading the companys regulatory strategy and for assuring quality of manufacturing and clinical operations she brings to the position  years of industry experience with over a decade in regulatory affairs for a broad range of medical products including most recently leading regulatory activities at argos therapeutics for complex cellular immunotherapies in oncology ms oyaski holds regulatory affairs certification rac for both the us and eu she also holds a master of science in cell and molecular biology from the university of pennsylvania and a master of arts in history and philosophy of science from the university of pittsburgh brandon early joins heat as senior director of clinical affairs and will assume overall responsibility for the execution of the companys clinical strategy  mr early brings to heat biologics deep clinical experience in oncology and immunology having led global oncology programs at inc research  mr early began his career as a clinical research coordinator at the university of virginia in the carter immunology center and asthma and allergic disease division  he has published his immunology research in several peerreviewed journals he holds a masters degree in clinical research from the university of virginia  about heat biologics inc  heat biologics inc wwwheatbiocom is a clinicalstage biopharmaceutical company focused on developing its novel offtheshelf impact therapeutic vaccines to combat a wide range of cancers our impact therapy is designed to deliver live geneticallymodified irradiated human cells which are reprogrammed to pump out a broad spectrum of cancerassociated antigens together with a potent immune adjuvant called gp to educate and activate a cancer patients immune system to recognize and kill cancerous cells heat is conducting a phase  trial of its viagenpumatucell hs in patients with nonsmall cell lung cancer as well as a phase  with its vesigenurtacell hs in patients with nonmuscle invasive bladder cancer forward looking statements this press release includes forwardlooking statements on our current expectations and projections about future events in some cases forwardlooking statements can be identified by terminology such as may should potential continue expects anticipates intends plans believes estimates and similar expressions these statements are based upon current beliefs expectations and assumptions and include statements regarding the expected contribution of each of the new team members and the potential for heats impact therapy these statements are subject to a number of risks and uncertainties many of which are difficult to predict including the ability for heats impact therapy to perform as designed and ability to successfully integrate the new team members and the other factors described in our annual report on form k for the year ended december   and our other filings with the sec the information in this release is provided only as of the date of this release and we undertake no obligation to update any forwardlooking statements contained in this release based on new information future events or otherwise except as required by law contact heat biologics inc contact information matthew czajkowski chief financial officer   mattheatbiocom investor relations michael wood lifesci advisors llc    source heat biologics released december   leadership  heat biologics inc htbx home about heat leadership heat biologics’ core team has all been personally touched by cancer or has witnessed firsthand the devastating effects of cancer or its current treatment methods on loved ones we are fully dedicated to helping to eradicate cancer through the development of safer more effective therapies that enhance the immune system instead of destroying it  jeffrey wolf founder and ceo jeffrey wolf is founder and ceo of heat biologics and cofounder of pelican therapeutics he also founded seedone ventures and served as managing director for the company which was focused on the systematic formation and management of new biomedical companies based upon novel research breakthroughs throughout his career mr wolf has specialized in building lifescience startup organizations and has played an active role in supporting the growth of his companies mr wolfs startups include avigen cofounder and director a nasdaqlisted gene therapy company tyrx pharma cofounder and chairman which was focused on the development of novel biocompatible polymers and recently sold to medtronic elusys therapeutics founder and ceo focused on the development of novel antibodies against infectious diseases and generationone founder and ceo a mobilebased healthcare solutions company mr wolf received his mba from stanford business school his jd from new york university school of law and his ba from the university of chicago where he graduated with honors in economics jeff hutchins phd chief scientific officer and senior vice president preclinical research heat biologics and pelican therapeutics as chief scientific officer and senior vice president preclinical development jeff hutchins oversees the research and development efforts for heat biologics as well as for the company’s subsidiary pelican therapeutics he brings more than  years of research and clinical development experience from both pharmaceutical and biotechnologyfocused companies most recently dr hutchins served as vice president of preclinical research for peregrine pharmaceuticals inc a biopharmaceutical company developing therapeutics to fight cancer and infectious diseases dr hutchins was responsible for building out the research program for peregrines lead product candidate bavituximab a chimeric monoclonal antibody designed to target phosphatidylserine prior to joining peregrine in  dr hutchins served as vice president preclinical development at inhibitex inc which was acquired by bristolmyers squibb from  to  dr hutchins held several senior scientist positions in discovery research at burroughs wellcome and glaxo wellcome with a visiting professor appointment at rush medical college dr hutchins earned his phd in biomedical sciences from the university of texas health science center at the md anderson cancer center followed by postdoctoral training in the university of southern californias department of microbiology at the norris cancer center dr hutchins publications and patents span the fields of oncology infectious disease osteoarthritis and immunology he received his bs in biology from oral roberts university george peoples md facs chief medical officer us army col ret george e peoples md facs serves as heats chief medical officer dr peoples recently retired from  years of active duty as a surgeon and research scientist in the military he is the founder and director of cancer insight llc a clinical research and development organization dedicated to the discovering developing and testing for emerging biotechnologies specializing in cancer immunotherapy dr peoples is a professor of surgery at uniformed services university of the health sciences and a professor adjunct of surgical oncology at md anderson cancer center mdacc he is the past chair of the cancer program san antonio military medical center and the past deputy director of the united states military cancer institute dr peoples served as the chief of surgical oncology at walter reed amy medical center wramc from  to  and at sammc from  to  he is a graduate of the united states military academy west point and the johns hopkins school of medicine he completed his surgical training at harvards brigham and womens hospital and during that time also completed a postdoctoral fellowship at the laboratory of biologic cancer therapy at harvard medical school he then completed a surgical oncology fellowship at mdacc before becoming chief of surgical oncology at wramc he has written extensively on the immune response to cancer with over  peerreviewed manuscripts abstracts and book chapters ann rosar mba vice president of finance corporate secretary ann rosar has more than  years of finance experience within publicly held companies and more than  years of experience focusing on regulatory reporting requirements prior to serving as vp of finance at heat biologics ms rosar served as manager of financial reporting and accounting for liposcience inc acquired by labcorp a provider of specialized cardiovascular diagnostic tests from  to  she also held various roles from  to  at the oncology supportive care pharmaceutical company dara biosciences inc now midatech pharma us including vp of finance chief accounting officer and controller earlier in her career ms rosar had also been responsible for securities and exchange commission reporting audits and budget analysis at the business integration software provider cicero inc formerly level  systems as well as senior financial analystbusiness operations for nextel communications ms rosar received an mba in finance from the university of houston and received her undergraduate degree from north carolina state university overview  heat biologics inc htbx home investors overview email alerts tear sheet ir contacts rss news feed overview company profile heat biologics is a clinicalstage company focused on developing its novel offtheshelf impact therapeutic vaccines to combat a wide range of cancers and infectious diseases impact therapy exploits the natural ability of antigens to activate the immune system by utilizing live irradiated offtheshelf genetically modified cells injected into a patient designed to elicit a powerful immune response against the disease target heat’s impact therapy is based upon heat shock protein gp a chaperone protein found in all human cells and normally tethered to our cells with a leash called the kdel sequence impact therapy removes this kdel leash thus transforming allogeneic living cells into powerful miniature osmotic pumps that continually secrete gp and their chaperoned antigens to activate the immune system against the full spectrum of antigens expressed by a patient’s disease heat is currently conducting multiple clinical trials in two indications with its impact therapy based products hs to treat nonmuscle invasive bladder cancer nmibc and hs to treat nonsmall cell lung cancer nsclc corporate presentation view our latest corporate presentation view presentation view press releases recent news jul   •  am edt heat biologics appoints damien hallet as vice president of cmc development jul   •  am edt dr jeff hutchins appointed chief operating officer for heat biologics jun   •  am edt pelican therapeutics a subsidiary of heat biologics receives first tranche of  million cprit grant award stock snapshot htbx nasdaq price change q  quarterly results pdf html earnings release pdf html q filing zip xls html xbrl ir contacts corporate address heat biologics inc  capitola drive durham nc  investor relations melissa m conger t  mcongerheatbiocom transfer agent continental stock transfer  trust company  battery place th floor new york new york  t  email alerts sign up for breaking news sign up heat biologics inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies  pharma info market research report heat biologics inc  product pipeline review   published by global markets direct product code  published september   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license heat biologics inc  product pipeline review   published september   content info  pages description summary global markets directs heat biologics inc  product pipeline review   provides an overview of the heat biologics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of heat biologics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope the report provides brief overview of heat biologics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of heat biologics incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the heat biologics incs pipeline products reasons to buy evaluate heat biologics incs strategic position with total access to detailed information on its product pipeline assess the growth potential of heat biologics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the heat biologics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of heat biologics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of heat biologics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of heat biologics inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contents product code gmdhccdb table of contents table of contents list of tables list of figures heat biologics inc snapshot heat biologics inc overview key information key facts heat biologics inc  research and development overview key therapeutic areas heat biologics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy heat biologics inc  pipeline products glance heat biologics inc  clinical stage pipeline products phase ii productscombination treatment modalities heat biologics inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities heat biologics inc  drug profiles vesigenurtucell product description mechanism of action rd progress viagenpumatucell product description mechanism of action rd progress hs product description mechanism of action rd progress hs product description mechanism of action rd progress hs product description mechanism of action rd progress hshiv product description mechanism of action rd progress cell therapy for cancer product description mechanism of action rd progress heat biologics inc  pipeline analysis heat biologics inc  pipeline products by route of administration heat biologics inc  pipeline products by molecule type heat biologics inc  recent pipeline updates heat biologics inc  dormant projects heat biologics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables heat biologics inc key information heat biologics inc key facts heat biologics inc  pipeline by indication  heat biologics inc  pipeline by stage of development  heat biologics inc  monotherapy products in pipeline  heat biologics inc  phase ii  heat biologics inc  preclinical  heat biologics inc  discovery  heat biologics inc  pipeline by route of administration  heat biologics inc  pipeline by molecule type  heat biologics inc  recent pipeline updates  heat biologics inc  dormant developmental projects list of figures heat biologics inc  pipeline by top  indication  heat biologics inc  pipeline by stage of development  heat biologics inc  monotherapy products in pipeline  heat biologics inc  pipeline by top  route of administration  heat biologics inc  pipeline by top  molecule type  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved stockscountryunited states index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  htbx stock price  heat biologics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern p updated wall street isn’t ready for a point tumble in the dow industrials p barrons buzz robo  facebook and twitter trading on news p a wild week in washington p updated the dark side of cruises p trump to police dont be too nice p updated the highest paid athletes in the world in one chart p updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family p updated here are  coworkers you should avoid like the plague — especially in meetings p updated top  most annoying people you may want to unfriend on facebook p updated this is one person you should never unfriend on facebook to be replaced home investing quotes stocks united states htbx overview compare quotes stock screener earnings calendar sectors nasdaq htbx us nasdaq join td ameritrade find a broker heat biologics inc watchlist createhtbxalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones heat biologics suspends proposed common stock public offering the day after announcing it jul   at  am et by emma court heat biologics started at buy with  stock price target at roth capital jun   at  am et by tomi kilgore pharma ipos continue to fly out the door jul   at  pm et on the wall street journal recent news other news press releases heat biologics htbx investor presentation  slideshow heat biologics htbx investor presentation  slideshow may   at  am et on seeking alpha q heat biologics inc q heat biologics inc may   at  am et on edgar online  edg  q k k heat biologics inc mar   at  am et on edgar online  edg  q k heat bio prices stock offering at  shares down  premarket mar   at  am et on seeking alpha heat bios hs shows treatment effect in midstage lung cancer study shares ahead  premarket mar   at  am et on seeking alpha heat biologics gets delisting notice from nasdaq related to low bid price investors do their part shares up  premarket mar   at  am et on seeking alpha heat biologics advances hs to phase  development shares jump  premarket mar   at  am et on seeking alpha heat biologics buys pelican therapeutics in cash and stock deal mar   at  am et on seeking alpha heat biologics htbx presents at th annual biotech showcase  conference jan   at  am et on seeking alpha the top  microcap stocks to buy for  dec   at  pm et on investorplacecom these stocks gained more than  in november dec   at  pm et on zackscom heat biologics stock falls on negative bladder cancer data dec   at  am et on zackscom heat biologics lead product candidate flunks midstage bladder cancer study shares plummet  dec   at  am et on seeking alpha biggest movers in manufacturing stocks now – csbr nvet crr hes nov   at  am et on investorplacecom biggest movers in manufacturing stocks now – htbx caas reph time nov   at  am et on investorplacecom heat biologics htbx in focus stock moves  higher nov   at  am et on zackscom biggest movers in manufacturing stocks now – htbx cxrx agle ach nov   at  am et on investorplacecom hottest manufacturing stocks now – htbx rgls caas achn nov   at  pm et on investorplacecom  biotechnology stocks to sell now oct   at  am et on investorplacecom  biotechnology stocks to sell now sep   at  am et on investorplacecom stock performance review on biotech industry  athersys aveo pharma heat biologics and ignyta stock performance review on biotech industry  athersys aveo pharma heat biologics and ignyta jul   at  am et on pr newswire  prf dr jeff hutchins appointed chief operating officer for heat biologics dr jeff hutchins appointed chief operating officer for heat biologics jul   at  pm et on accesswire dr jeff hutchins appointed chief operating officer for heat biologics dr jeff hutchins appointed chief operating officer for heat biologics jul   at  am et on accesswire heat biologics appoints damien hallet as vice president of cmc development heat biologics appoints damien hallet as vice president of cmc development jul   at  am et on accesswire todays research reports on stocks to watch heat biologics inc and esperion therapeutics todays research reports on stocks to watch heat biologics inc and esperion therapeutics jun   at  am et on accesswire pelican therapeutics a subsidiary of heat biologics receives first tranche of  million cprit grant award pelican therapeutics a subsidiary of heat biologics receives first tranche of  million cprit grant award jun   at  am et on accesswire heat biologics to present at the  bio international convention heat biologics to present at the  bio international convention jun   at  am et on accesswire heat biologics to present at the  marcum microcap conference heat biologics to present at the  marcum microcap conference jun   at  am et on accesswire heat biologics presents poster on its phase  trial evaluating hs at asco annual meeting heat biologics presents poster on its phase  trial evaluating hs at asco annual meeting jun   at  am et on accesswire heat biologics to present poster at  asco annual meeting heat biologics to present poster at  asco annual meeting may   at  am et on accesswire biotech stocks on investors radar  progenics pharma dynavax technologies intrexon and heat biologics biotech stocks on investors radar  progenics pharma dynavax technologies intrexon and heat biologics may   at  am et on pr newswire  prf heat biologics provides business and clinical update for the first quarter of  heat biologics provides business and clinical update for the first quarter of  may   at  am et on accesswire heat biologics announces completion of acquisition of pelican therapeutics heat biologics announces completion of acquisition of pelican therapeutics may   at  am et on accesswire heat biologics to present at pioneers  presented by joseph gunnar  co apr   at  am et on globenewswire heat biologics presents new preclinical data from oncosec collaboration at the american association for cancer research aacr annual meeting apr   at  am et on globenewswire heat biologics reports fiscal year  financial results mar   at  am et on globenewswire heat biologics closes public offering of  shares of common stock mar   at  pm et on globenewswire heat biologics prices offering of  shares of common stock mar   at  am et on globenewswire heat biologics announces proposed public offering of common stock mar   at  pm et on globenewswire biotechs focus on improving cancer pain management for enhanced patient care mar   at  am et on pr newswire  prf heat biologics inc heat biologics inc is a clinicalstage biopharmaceutical company it focuses on developing proprietary cell based immune panantigen cytotoxic therapy impact the companys impact platform technology is used to treat patients with a wide array of cancers and infectious diseases this technology also develops product candidates that consist of live geneticallymodified and irradiated human cancer cells together with immune response stimulator gp heat biologics was founded by jeffrey alan wolf on june   and is headquartered in durham nc see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top initiations may   at  am et on benzingacom hc wainwright initiates heat biologics at buy may   at  am et on benzingacom competitors name chg  market cap celldex therapeutics inc  m bristolmyers squibb co  b eli lilly  co  b pfizer inc  b newlink genetics corp  m competitor data provided by partner content trending tickers powered by dvax  mo  ssti  blcm  s  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience security check required facebookjoin or log into facebook   email or phonepasswordforgot accountlog indo you want to join facebooksign upsign upsecurity checkplease enter the text belowcant read the text abovetry another text or an audio captchatext in the boxwhats thissecurity checkthis is a standard security test that we use to prevent spammers from creating fake accounts and spamming userssubmitenglish usespañolfrançais franceالعربيةportuguês brasilitaliano한국어deutschहिन्दीmessengerfacebook litepeopleplacesgameslocationscelebritiesmarketplacegroupsrecipesmomentsinstagramaboutcreate adcreate pagedeveloperscareersprivacycookiesad choicestermssettingsactivity log facebook   market report heat biologics inc  product pipeline review   about us • publishers • contact us • cart login  register all industries business  finance  business  financial services  insurance  marketing consumer  food  beverages  consumer goods  food  retailing healthcare  biotechnology  healthcare  medical devices  pharmaceuticals heavy industry  construction  energy  manufacturing  materials  transportation internet  media  ebusiness  internet  media  publishing public sector  defense  education  government telecom  computing  computer technology  fixed networks  software  wireless companycountry reports  company reports  country reports  regional reports   processing heat biologics inc  product pipeline review   sep    global markets direct   pages  usd  click here to open the popup youve added the following report to your cartclose cart summary total items subtotal      report summary table of contents companies request details related global markets directs heat biologics inc  product pipeline review   provides an overview of the heat biologics incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of heat biologics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasereport scopethe report provides brief overview of heat biologics inc including business description key information and facts and its locations and subsidiariesthe report reviews current pipeline of heat biologics incs human therapeutic division and enlists all their major and minor projectsthe report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestonesspecial feature on outlicensed and partnered product portfoliothe report summarizes all the dormant and discontinued pipeline projectslatest company statementlatest news and deals relating to the heat biologics incs pipeline productsreasons to get this reportevaluate heat biologics incs strategic position with total access to detailed information on its product pipelineassess the growth potential of heat biologics inc in its therapy areas of focusidentify new drug targets and therapeutic classes in the heat biologics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areasexploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gapsdevelop strategic initiatives by understanding the focus areas of heat biologics inc and exploit collaboration and partnership opportunitiesidentify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantageplan mergers and acquisitions effectively by identifying the most promising pipeline of heat biologics incdevelop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scopeexplore the dormant and discontinued projects of heat biologics inc and identify potential opportunities in those areasavoid intellectual property rights related issues table of contentstable of contents list of tables list of figures heat biologics inc snapshot heat biologics inc overview key information key facts heat biologics inc  research and development overview key therapeutic areas heat biologics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy heat biologics inc  pipeline products glance heat biologics inc  clinical stage pipeline products phase ii productscombination treatment modalities heat biologics inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities heat biologics inc  drug profiles vesigenurtucell product description mechanism of action rd progress viagenpumatucell product description mechanism of action rd progress hs product description mechanism of action rd progress hs product description mechanism of action rd progress hs product description mechanism of action rd progress hshiv product description mechanism of action rd progress cell therapy for cancer product description mechanism of action rd progress heat biologics inc  pipeline analysis heat biologics inc  pipeline products by route of administration heat biologics inc  pipeline products by molecule type heat biologics inc  recent pipeline updates heat biologics inc  dormant projects heat biologics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesheat biologics inc key information heat biologics inc key facts heat biologics inc  pipeline by indication  heat biologics inc  pipeline by stage of development  heat biologics inc  monotherapy products in pipeline  heat biologics inc  phase ii  heat biologics inc  preclinical  heat biologics inc  discovery  heat biologics inc  pipeline by route of administration  heat biologics inc  pipeline by molecule type  heat biologics inc  recent pipeline updates  heat biologics inc  dormant developmental projects list of figuresheat biologics inc  pipeline by top  indication  heat biologics inc  pipeline by stage of development  heat biologics inc  monotherapy products in pipeline  heat biologics inc  pipeline by top  route of administration  heat biologics inc  pipeline by top  molecule type   companies mentioned in this reportheat biologics inc this report does not have a press release associated with it order today format pdf  usd license single user delivery by email   business day the fast market research advantage only the best all of our research is sourced from the most trusted and established global analysts and consultancies client focused from startups to multinationals we focus on providing the right research to our diverse client base shop securely our usbased customer service team and ecommerce systems adhere to the highest data security standards industryleading customer support individualized assistance from our expert staff is never more than an email or phone call away best price guarantee we are committed to providing the best research at the lowest cost we will match any published price for the same report guaranteed easy ordering once you’ve found the right report click ‘order now’ and complete the checkout process using any major credit card check or wirebank transferneed multiuser or enterprise license pricing contact us for a custom quote about the publisher global markets direct is a leading provider of global business intelligence and market analysis it publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industryspecific information publisher details privacy policy  terms of use  flashalerts copyright copy  fast market research inc heat biologics  wikipedia heat biologics from wikipedia the free encyclopedia jump to navigation search this article is an orphan as no other articles link to it please introduce links to this page from related articles try the find link tool for suggestions january  heat biologics type public traded as nasdaq htbx industry biotechnology founded  headquarters durham nc key people jeffrey wolf chairman and chief executive officer products hs hsx website wwwheatbiocom heat biologics inc is a us biotechnology company focused on the field of cancer immunotherapy this company’s cancer vaccine is called impact short for immune panantigen cytotoxic therapy impact is in phase ii in nsclc and bladder cancer contents  impact  compact  other potential products  hs  hs  heat biologics stock  main people  location  references impactedit impact is a proposed cancer vaccine based on live geneticallymodified irradiated human cells which secrete a broad spectrum of cancerassociated antigens as well as an immune adjuvant called gp potential advantages of this product are use as an allogeneic that is offtheshelf immunotherapy and its appplicability to a wide range of cancers it is in phase ii trials impact originated in the late s in work done at the university of miami which showed that gp a heat shock protein resident in the endoplasmic reticulum could be made immunogenic if part of gp was replaced with the fc portion of an igg antibody to engineer a secretory form of gp in vivo gpig generated a strong cd t cell response compactedit compact is a combination of a panantigen t cell priming vaccine and a t cell costimulator other potential productsedit hsedit hs also called vesigenurtacell is currently in phase ii in nonmuscleinvasive bladder cancer nmibc in combination with bcg in feb  patient enrollment was paused for lack of bcg hsedit hs  called viagenpumatucell is in phase ii in nsclc in combination with cyclophosphamide another phase i study is combining hs  with nivolumab and other checkpoint inhibitors heat biologics stockedit heat biologics stock is traded on nasdaq under the code htbx the company did its ipo on nasdaq in mid with its stock commencing trading on  july  main peopleedit heat biologics chairman and ceo is jeffrey wolf a serial life sciences entrepreneur who founded the company in  its chief scientific officer dr taylor schreiber is a coinventor of the impact platform locationedit heat biologics is headquartered in durham nc its office at  capitola drive is located near the i about three miles to the southwest of research triangle park and eight miles to the west of raleigh–durham international airport referencesedit  yamazaki k nguyen t podack er november   cutting edge tumor secreted heat shockfusion protein elicits cd cells for rejection nucleic acids res   – pmid  doinargkq   t cell therapies heat up as biotech looks to third public offering feb   a phase  study of hs in patients with nonmuscle invasive bladder cancer after turbt  heat biologics stops enrolment in trial arm testing hs as a bladder cancer monotherapy feb   heat biologics inc announces closing of initial public offering of  shares of common stock heatbiocom july   retrieved  january   retrieved from httpsenwikipediaorgwindexphptitleheatbiologicsoldid categories biotechnology companieshidden categories orphaned articles from january all orphaned articles navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  november  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view heat biologics  wikipedia heat biologics from wikipedia the free encyclopedia jump to navigation search this article is an orphan as no other articles link to it please introduce links to this page from related articles try the find link tool for suggestions january  heat biologics type public traded as nasdaq htbx industry biotechnology founded  headquarters durham nc key people jeffrey wolf chairman and chief executive officer products hs hsx website wwwheatbiocom heat biologics inc is a us biotechnology company focused on the field of cancer immunotherapy this company’s cancer vaccine is called impact short for immune panantigen cytotoxic therapy impact is in phase ii in nsclc and bladder cancer contents  impact  compact  other potential products  hs  hs  heat biologics stock  main people  location  references impactedit impact is a proposed cancer vaccine based on live geneticallymodified irradiated human cells which secrete a broad spectrum of cancerassociated antigens as well as an immune adjuvant called gp potential advantages of this product are use as an allogeneic that is offtheshelf immunotherapy and its appplicability to a wide range of cancers it is in phase ii trials impact originated in the late s in work done at the university of miami which showed that gp a heat shock protein resident in the endoplasmic reticulum could be made immunogenic if part of gp was replaced with the fc portion of an igg antibody to engineer a secretory form of gp in vivo gpig generated a strong cd t cell response compactedit compact is a combination of a panantigen t cell priming vaccine and a t cell costimulator other potential productsedit hsedit hs also called vesigenurtacell is currently in phase ii in nonmuscleinvasive bladder cancer nmibc in combination with bcg in feb  patient enrollment was paused for lack of bcg hsedit hs  called viagenpumatucell is in phase ii in nsclc in combination with cyclophosphamide another phase i study is combining hs  with nivolumab and other checkpoint inhibitors heat biologics stockedit heat biologics stock is traded on nasdaq under the code htbx the company did its ipo on nasdaq in mid with its stock commencing trading on  july  main peopleedit heat biologics chairman and ceo is jeffrey wolf a serial life sciences entrepreneur who founded the company in  its chief scientific officer dr taylor schreiber is a coinventor of the impact platform locationedit heat biologics is headquartered in durham nc its office at  capitola drive is located near the i about three miles to the southwest of research triangle park and eight miles to the west of raleigh–durham international airport referencesedit  yamazaki k nguyen t podack er november   cutting edge tumor secreted heat shockfusion protein elicits cd cells for rejection nucleic acids res   – pmid  doinargkq   t cell therapies heat up as biotech looks to third public offering feb   a phase  study of hs in patients with nonmuscle invasive bladder cancer after turbt  heat biologics stops enrolment in trial arm testing hs as a bladder cancer monotherapy feb   heat biologics inc announces closing of initial public offering of  shares of common stock heatbiocom july   retrieved  january   retrieved from httpsenwikipediaorgwindexphptitleheatbiologicsoldid categories biotechnology companieshidden categories orphaned articles from january all orphaned articles navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  november  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view heat biologics inc  product pipeline review   infomarketreportscentercom  us x login sign up facebook twitter linkedin google  mrc blog youtube heat biologics inc  product pipeline review   home  pharmaceuticals  global markets direct  heat biologics inc  product pipeline review   report details heat biologics inc  product pipeline review   sku gmdsep category pharmaceuticals publisher global markets direct pages  published sep skugmdsep categorypharmaceuticals publisherglobal markets direct pages published onsep request discount pay by wireinvoice description table of content list of figures request sample description heat biologics inc  product pipeline review   summary global markets directs heat biologics inc  product pipeline review   provides an overview of the heat biologics incs pharmaceutical research and development focus this report provides comprehensive information on the current therapeutic developmental pipeline of heat biologics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis the report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass products note certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease scope  the report provides brief overview of heat biologics inc including business description key information and facts and its locations and subsidiaries  the report reviews current pipeline of heat biologics incs human therapeutic division and enlists all their major and minor projects  the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones  special feature on outlicensed and partnered product portfolio  the report summarizes all the dormant and discontinued pipeline projects  latest company statement  latest news and deals relating to the heat biologics incs pipeline products reasons to buy  evaluate heat biologics incs strategic position with total access to detailed information on its product pipeline  assess the growth potential of heat biologics inc in its therapy areas of focus  identify new drug targets and therapeutic classes in the heat biologics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas  exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps  develop strategic initiatives by understanding the focus areas of heat biologics inc and exploit collaboration and partnership opportunities  identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage  plan mergers and acquisitions effectively by identifying the most promising pipeline of heat biologics inc  develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope  explore the dormant and discontinued projects of heat biologics inc and identify potential opportunities in those areas  avoid intellectual property rights related issues newspress release precision medicine how the life science industry can improve outcomes through to achieve successful precision medicine at scale and to be able to offer it as an everyday treatment option researchers in drug rd need to better understand and manage the reams of unstructured datread more regenerative medicine market to hit  billion by  the current regenerative medicine market is worth  billion globally and will hit over  billion by  as impact of trump administrationread more  benefits of microneedlingmicroneedling hundreds of tiny pin pricks going into your skin might sound weird but it could just be the best thing that ever happened to your faceread more table of content table of contents table of contents  list of tables  list of figures  heat biologics inc snapshot  heat biologics inc overview  key information  key facts  heat biologics inc  research and development overview  key therapeutic areas  heat biologics inc  pipeline review  pipeline products by stage of development  pipeline products  monotherapy  heat biologics inc  pipeline products glance  heat biologics inc  clinical stage pipeline products  phase ii productscombination treatment modalities  heat biologics inc  early stage pipeline products  preclinical productscombination treatment modalities  discovery productscombination treatment modalities  heat biologics inc  drug profiles  vesigenurtucell  product description  mechanism of action  rd progress  viagenpumatucell  product description  mechanism of action  rd progress  hs  product description  mechanism of action  rd progress  hs  product description  mechanism of action  rd progress  hs  product description  mechanism of action  rd progress  hshiv  product description  mechanism of action  rd progress  cell therapy for cancer  product description  mechanism of action  rd progress  heat biologics inc  pipeline analysis  heat biologics inc  pipeline products by route of administration  heat biologics inc  pipeline products by molecule type  heat biologics inc  recent pipeline updates  heat biologics inc  dormant projects  heat biologics inc  locations and subsidiaries  head office  appendix  methodology  coverage  secondary research  primary research  expert panel validation  contact us  disclaimer  list of figures list of tables heat biologics inc key information  heat biologics inc key facts  heat biologics inc  pipeline by indication   heat biologics inc  pipeline by stage of development   heat biologics inc  monotherapy products in pipeline   heat biologics inc  phase ii   heat biologics inc  preclinical   heat biologics inc  discovery   heat biologics inc  pipeline by route of administration   heat biologics inc  pipeline by molecule type   heat biologics inc  recent pipeline updates   heat biologics inc  dormant developmental projects  list of figures heat biologics inc  pipeline by top  indication   heat biologics inc  pipeline by stage of development   heat biologics inc  monotherapy products in pipeline   heat biologics inc  pipeline by top  route of administration   heat biologics inc  pipeline by top  molecule type   please select license type single user electronic pdf   site user electronic pdf   enterprise wide electronic pdf   add to cart buy now related reports global incoloy alloy ma  sales market report  global zinc dimethyldithiocarbamate market research report  global grate bars for refuse incinerators industry report  global and chinese zinc trifluoromethanesulphonate cas  industry  market research report global and chinese zinc fumarate cas  industry  market research report request sample mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send request discount mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send pay by wireinvoice mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  single user electronic pdf site user electronic pdf enterprise wide electronic pdf cd rom hard copy send request quote mr mrs ms dr afghanistan  albania  algeria  andorra  angola  antigua and barbuda  argentina  armenia  australia  austria  azerbaijan  bahamas the  bahrain  bangladesh  barbados  belarus  belgium  belize  benin  bhutan  bolivia  bosnia and herzegovina  botswana  brazil  brunei  bulgaria  burkina faso  burundi  cambodia  cameroon  canada  cape verde  central african republic  chad  chile  china peoples republic of  colombia  comoros  congo congo  kinshasa  congo congo  brazzaville  costa rica  cote divoire ivory coast  croatia  cuba  cyprus  czech republic  denmark  djibouti  dominica  dominican republic  and  ecuador  egypt  el salvador  equatorial guinea  eritrea  estonia  ethiopia  fiji  finland  france  gabon  gambia the  georgia  germany  ghana  greece  grenada  guatemala  guinea  guineabissau  guyana  haiti  honduras  hungary  iceland  india  indonesia  iran  iraq  ireland  israel  italy  jamaica  japan  jordan  kazakhstan  kenya  kiribati  korea north  korea south  kuwait  kyrgyzstan  laos  latvia  lebanon  lesotho  liberia  libya  liechtenstein  lithuania  luxembourg  macedonia  madagascar  malawi  malaysia  maldives  mali  malta  marshall islands  mauritania  mauritius  mexico  micronesia  moldova  monaco  mongolia  montenegro  morocco  mozambique  myanmar burma  namibia  nauru  nepal  netherlands  new zealand  nicaragua  niger  nigeria  norway  oman  pakistan  palau  panama  papua new guinea  paraguay  peru  philippines  poland  portugal  qatar  romania  russia  rwanda  saint kitts and nevis  saint lucia  saint vincent and the grenadines  samoa  san marino  sao tome and principe  saudi arabia  senegal  serbia  seychelles  sierra leone  singapore  slovakia  slovenia  solomon islands  somalia  south africa  spain  sri lanka  sudan  suriname  swaziland  sweden  switzerland  syria  tajikistan  tanzania  thailand  timorleste east timor  togo  tonga  trinidad and tobago  tunisia  turkey  turkmenistan  tuvalu  uganda  ukraine  united arab emirates  united kingdom  united states  uruguay  uzbekistan  vanuatu  vatican city  venezuela  vietnam  yemen  zambia  zimbabwe  abkhazia  china republic of taiwan  nagornokarabakh  northern cyprus  pridnestrovie transnistria  somaliland  south ossetia  ashmore and cartier islands  christmas island  cocos keeling islands  coral sea islands  heard island and mcdonald islands  norfolk island  new caledonia  french polynesia  mayotte  saint barthelemy  saint martin  saint pierre and miquelon  wallis and futuna  french southern and antarctic lands  clipperton island  bouvet island  cook islands  niue  tokelau  guernsey  isle of man  jersey  anguilla  bermuda  british indian ocean territory  british sovereign base areas  british virgin islands  cayman islands  falkland islands islas malvinas  gibraltar  montserrat  pitcairn islands  saint helena  south georgia  south sandwich islands  turks and caicos islands  northern mariana islands  puerto rico  and  american samoa  baker island  guam  howland island  jarvis island  johnston atoll  kingman reef  midway islands  navassa island  palmyra atoll  us virgin islands  wake island  hong kong  macau  faroe islands  greenland  french guiana  guadeloupe  martinique  reunion  aland  aruba  netherlands antilles  svalbard  ascension  tristan da cunha  australian antarctic territory  ross dependency  peter i island  queen maud land  british antarctic territory  send market reports center  copyright  all rights reserved creative commons — attributionsharealike  unported — cc bysa  skip to content menu help us build a vibrant collaborative global commons donate now creative commons creative commons license deed attributionsharealike  unported cc bysa  this is a humanreadable summary of and not a substitute for the license disclaimer you are free to share — copy and redistribute the material in any medium or format adapt — remix transform and build upon the material for any purpose even commercially the licensor cannot revoke these freedoms as long as you follow the license terms under the following terms attribution — you must give appropriate credit provide a link to the license and indicate if changes were made you may do so in any reasonable manner but not in any way that suggests the licensor endorses you or your use attribute this work sharealike — if you remix transform or build upon the material you must distribute your contributions under the same license as the original no additional restrictions — you may not apply legal terms or technological measures that legally restrict others from doing anything the license permits notices you do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation no warranties are given the license may not give you all of the permissions necessary for your intended use for example other rights such as publicity privacy or moral rights may limit how you use the material learn more about cc licensing or use the license for your own material this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work make a donation this page is available in the following languages castellano castellano españa català dansk deutsch english esperanto français galego hrvatski indonesia italiano latviski lietuvių melayu nederlands norsk polski português português br română slovenščina suomeksi svenska türkçe íslenska česky ελληνικά беларуская русский українська العربية پارسی     한국어 this content is freely available under simple legal terms because of creative commons a nonprofit that survives on donations if you love this content and love that its free for everyone please consider a donation to support our work when you share everyone wins contribute today to creative commons     disclaimer this deed highlights only some of the key features and terms of the actual license it is not a license and has no legal value you should carefully review all of the terms and conditions of the actual license before using the licensed material creative commons is not a law firm and does not provide legal services distributing displaying or linking to this deed or the license that it summarizes does not create a lawyerclient or any other relationship what does attribute this work mean the page you came from contained embedded licensing metadata including how the creator wishes to be attributed for reuse you can use the html here to cite the work doing so will also include metadata on your page so that others can find the original work as well the applicable mediation rules will be designated in the copyright notice published with the work or if none then in the request for mediation unless otherwise designated in a copyright notice attached to the work the uncitral arbitration rules apply to any arbitration more info if supplied you must provide the name of the creator and attribution parties a copyright notice a license notice a disclaimer notice and a link to the material cc licenses prior to version  also require you to provide the title of the material if supplied and may have other slight differences more info in  you must indicate if you modified the material and retain an indication of previous modifications in  and earlier license versions the indication of changes is only required if you create a derivative marking guide more info you may also use a license listed as compatible at httpscreativecommonsorgcompatiblelicenses more info a commercial use is one primarily intended for commercial advantage or monetary compensation more info merely changing the format never creates a derivative more info the license prohibits application of effective technological measures defined with reference to article  of the wipo copyright treaty more info the rights of users under exceptions and limitations such as fair use and fair dealing are not affected by the cc licenses more info you may need to get additional permissions before using the material as you intend more info htbx stock price  heat biologics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern p updated wall street isn’t ready for a point tumble in the dow industrials p barrons buzz robo  facebook and twitter trading on news p a wild week in washington p updated the dark side of cruises p trump to police dont be too nice p updated the highest paid athletes in the world in one chart p updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family p updated here are  coworkers you should avoid like the plague — especially in meetings p updated top  most annoying people you may want to unfriend on facebook p updated this is one person you should never unfriend on facebook to be replaced home investing quotes stocks united states htbx overview compare quotes stock screener earnings calendar sectors nasdaq htbx us nasdaq join td ameritrade find a broker heat biologics inc watchlist createhtbxalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones heat biologics suspends proposed common stock public offering the day after announcing it jul   at  am et by emma court heat biologics started at buy with  stock price target at roth capital jun   at  am et by tomi kilgore pharma ipos continue to fly out the door jul   at  pm et on the wall street journal recent news other news press releases heat biologics htbx investor presentation  slideshow heat biologics htbx investor presentation  slideshow may   at  am et on seeking alpha q heat biologics inc q heat biologics inc may   at  am et on edgar online  edg  q k k heat biologics inc mar   at  am et on edgar online  edg  q k heat bio prices stock offering at  shares down  premarket mar   at  am et on seeking alpha heat bios hs shows treatment effect in midstage lung cancer study shares ahead  premarket mar   at  am et on seeking alpha heat biologics gets delisting notice from nasdaq related to low bid price investors do their part shares up  premarket mar   at  am et on seeking alpha heat biologics advances hs to phase  development shares jump  premarket mar   at  am et on seeking alpha heat biologics buys pelican therapeutics in cash and stock deal mar   at  am et on seeking alpha heat biologics htbx presents at th annual biotech showcase  conference jan   at  am et on seeking alpha the top  microcap stocks to buy for  dec   at  pm et on investorplacecom these stocks gained more than  in november dec   at  pm et on zackscom heat biologics stock falls on negative bladder cancer data dec   at  am et on zackscom heat biologics lead product candidate flunks midstage bladder cancer study shares plummet  dec   at  am et on seeking alpha biggest movers in manufacturing stocks now – csbr nvet crr hes nov   at  am et on investorplacecom biggest movers in manufacturing stocks now – htbx caas reph time nov   at  am et on investorplacecom heat biologics htbx in focus stock moves  higher nov   at  am et on zackscom biggest movers in manufacturing stocks now – htbx cxrx agle ach nov   at  am et on investorplacecom hottest manufacturing stocks now – htbx rgls caas achn nov   at  pm et on investorplacecom  biotechnology stocks to sell now oct   at  am et on investorplacecom  biotechnology stocks to sell now sep   at  am et on investorplacecom stock performance review on biotech industry  athersys aveo pharma heat biologics and ignyta stock performance review on biotech industry  athersys aveo pharma heat biologics and ignyta jul   at  am et on pr newswire  prf dr jeff hutchins appointed chief operating officer for heat biologics dr jeff hutchins appointed chief operating officer for heat biologics jul   at  pm et on accesswire dr jeff hutchins appointed chief operating officer for heat biologics dr jeff hutchins appointed chief operating officer for heat biologics jul   at  am et on accesswire heat biologics appoints damien hallet as vice president of cmc development heat biologics appoints damien hallet as vice president of cmc development jul   at  am et on accesswire todays research reports on stocks to watch heat biologics inc and esperion therapeutics todays research reports on stocks to watch heat biologics inc and esperion therapeutics jun   at  am et on accesswire pelican therapeutics a subsidiary of heat biologics receives first tranche of  million cprit grant award pelican therapeutics a subsidiary of heat biologics receives first tranche of  million cprit grant award jun   at  am et on accesswire heat biologics to present at the  bio international convention heat biologics to present at the  bio international convention jun   at  am et on accesswire heat biologics to present at the  marcum microcap conference heat biologics to present at the  marcum microcap conference jun   at  am et on accesswire heat biologics presents poster on its phase  trial evaluating hs at asco annual meeting heat biologics presents poster on its phase  trial evaluating hs at asco annual meeting jun   at  am et on accesswire heat biologics to present poster at  asco annual meeting heat biologics to present poster at  asco annual meeting may   at  am et on accesswire biotech stocks on investors radar  progenics pharma dynavax technologies intrexon and heat biologics biotech stocks on investors radar  progenics pharma dynavax technologies intrexon and heat biologics may   at  am et on pr newswire  prf heat biologics provides business and clinical update for the first quarter of  heat biologics provides business and clinical update for the first quarter of  may   at  am et on accesswire heat biologics announces completion of acquisition of pelican therapeutics heat biologics announces completion of acquisition of pelican therapeutics may   at  am et on accesswire heat biologics to present at pioneers  presented by joseph gunnar  co apr   at  am et on globenewswire heat biologics presents new preclinical data from oncosec collaboration at the american association for cancer research aacr annual meeting apr   at  am et on globenewswire heat biologics reports fiscal year  financial results mar   at  am et on globenewswire heat biologics closes public offering of  shares of common stock mar   at  pm et on globenewswire heat biologics prices offering of  shares of common stock mar   at  am et on globenewswire heat biologics announces proposed public offering of common stock mar   at  pm et on globenewswire biotechs focus on improving cancer pain management for enhanced patient care mar   at  am et on pr newswire  prf heat biologics inc heat biologics inc is a clinicalstage biopharmaceutical company it focuses on developing proprietary cell based immune panantigen cytotoxic therapy impact the companys impact platform technology is used to treat patients with a wide array of cancers and infectious diseases this technology also develops product candidates that consist of live geneticallymodified and irradiated human cancer cells together with immune response stimulator gp heat biologics was founded by jeffrey alan wolf on june   and is headquartered in durham nc see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top initiations may   at  am et on benzingacom hc wainwright initiates heat biologics at buy may   at  am et on benzingacom competitors name chg  market cap celldex therapeutics inc  m bristolmyers squibb co  b eli lilly  co  b pfizer inc  b newlink genetics corp  m competitor data provided by partner content trending tickers powered by dvax  mo  ssti  blcm  s  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience heat biologics  wikipedia heat biologics from wikipedia the free encyclopedia jump to navigation search this article is an orphan as no other articles link to it please introduce links to this page from related articles try the find link tool for suggestions january  heat biologics type public traded as nasdaq htbx industry biotechnology founded  headquarters durham nc key people jeffrey wolf chairman and chief executive officer products hs hsx website wwwheatbiocom heat biologics inc is a us biotechnology company focused on the field of cancer immunotherapy this company’s cancer vaccine is called impact short for immune panantigen cytotoxic therapy impact is in phase ii in nsclc and bladder cancer contents  impact  compact  other potential products  hs  hs  heat biologics stock  main people  location  references impactedit impact is a proposed cancer vaccine based on live geneticallymodified irradiated human cells which secrete a broad spectrum of cancerassociated antigens as well as an immune adjuvant called gp potential advantages of this product are use as an allogeneic that is offtheshelf immunotherapy and its appplicability to a wide range of cancers it is in phase ii trials impact originated in the late s in work done at the university of miami which showed that gp a heat shock protein resident in the endoplasmic reticulum could be made immunogenic if part of gp was replaced with the fc portion of an igg antibody to engineer a secretory form of gp in vivo gpig generated a strong cd t cell response compactedit compact is a combination of a panantigen t cell priming vaccine and a t cell costimulator other potential productsedit hsedit hs also called vesigenurtacell is currently in phase ii in nonmuscleinvasive bladder cancer nmibc in combination with bcg in feb  patient enrollment was paused for lack of bcg hsedit hs  called viagenpumatucell is in phase ii in nsclc in combination with cyclophosphamide another phase i study is combining hs  with nivolumab and other checkpoint inhibitors heat biologics stockedit heat biologics stock is traded on nasdaq under the code htbx the company did its ipo on nasdaq in mid with its stock commencing trading on  july  main peopleedit heat biologics chairman and ceo is jeffrey wolf a serial life sciences entrepreneur who founded the company in  its chief scientific officer dr taylor schreiber is a coinventor of the impact platform locationedit heat biologics is headquartered in durham nc its office at  capitola drive is located near the i about three miles to the southwest of research triangle park and eight miles to the west of raleigh–durham international airport referencesedit  yamazaki k nguyen t podack er november   cutting edge tumor secreted heat shockfusion protein elicits cd cells for rejection nucleic acids res   – pmid  doinargkq   t cell therapies heat up as biotech looks to third public offering feb   a phase  study of hs in patients with nonmuscle invasive bladder cancer after turbt  heat biologics stops enrolment in trial arm testing hs as a bladder cancer monotherapy feb   heat biologics inc announces closing of initial public offering of  shares of common stock heatbiocom july   retrieved  january   retrieved from httpsenwikipediaorgwindexphptitleheatbiologicsoldid categories biotechnology companieshidden categories orphaned articles from january all orphaned articles navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  november  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view heat biologics inc  product pipeline review   infowiseguyreportscom     chat with us           us         uk login register home report categories premium reports access to  premium reports aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports report categories aerospace  defense agri  food automotive basic materials consumer goods  retail energy life sciences manufacturing  construction services telecom  it education security  intelligence systems technology company reports publisher knowledgestore countries browse by country browse by continent browse by group  region conferences upcoming conferences seminars conferences upcoming conferences seminars countries browse by country browse by continent browse by group  region news  blog press release blog news  blogs press release blogs faqs about us about our company our team life at wgr careers contact us there are no items currently in your basket there are no items currently in your basket search home all reports heat biologics inc  product pipeline review   heat biologics inc  product pipeline review   wgr  march  global  pages global markets direct description table of content sample report enquiry before buy related reports heat biologics inc  product pipeline review  summaryglobal markets direct’s ‘heat biologics inc  product pipeline review  ’ provides an overview of the heat biologics inc’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of heat biologics inc’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets direct’s report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets direct’s proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets direct’s team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of heat biologics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of heat biologics inc’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the heat biologics inc’s pipeline productsreasons to buy evaluate heat biologics inc’s strategic position with total access to detailed information on its product pipeline assess the growth potential of heat biologics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the heat biologics inc’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of heat biologics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of heat biologics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of heat biologics inc and identify potential opportunities in those areas avoid intellectual property rights related issues table of contentstable of contents list of tables list of figures heat biologics inc snapshot heat biologics inc overview key information key facts heat biologics inc  research and development overview key therapeutic areas heat biologics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy heat biologics inc  pipeline products glance heat biologics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities heat biologics inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities heat biologics inc  drug profiles viagenpumatucell product description mechanism of action rd progress hs product description mechanism of action rd progress hs product description mechanism of action rd progress hs product description mechanism of action rd progress hs product description mechanism of action rd progress hs product description mechanism of action rd progress cell therapy for cancer product description mechanism of action rd progress heat biologics inc  pipeline analysis heat biologics inc  pipeline products by route of administration heat biologics inc  pipeline products by molecule type heat biologics inc  recent pipeline updates heat biologics inc  dormant projects heat biologics inc  locations and subsidiaries head office appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tablesheat biologics inc key information heat biologics inc key facts heat biologics inc  pipeline by indication  heat biologics inc  pipeline by stage of development  heat biologics inc  monotherapy products in pipeline  heat biologics inc  phase ii  heat biologics inc  phase i  heat biologics inc  preclinical  heat biologics inc  discovery  heat biologics inc  pipeline by route of administration  heat biologics inc  pipeline by molecule type  heat biologics inc  recent pipeline updates  heat biologics inc  dormant developmental projects list of figuresheat biologics inc  pipeline by top  indication  heat biologics inc  pipeline by stage of development  heat biologics inc  monotherapy products in pipeline  heat biologics inc  pipeline by top  route of administration  heat biologics inc  pipeline by top  molecule type   request a sample report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro do you have any specific field of interest confirm make an enquiry before buying this report name email optional request you to please fill in your corporate emailid job title company phone no your country select country afghanistan albania algeria american samoa andorra angola anguilla antigua  barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia  herzegovina botswana brazil brunei bulgaria burkina faso burundi cambodja cameroon canada cape verde cayman islands central african republic chad chile china colombia comoros congobrazzaville congokinshasa cook islands costa rica cote divoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland malvinas faroes fiji finland france frenchguiana tahitifrench polinesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti vatican city honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy jamaica japan jordan kazakhstan kenya kiribati north korea south korea kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macao macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mexico micronesia moldova monaco mongolia montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria norfolk northern mariana norway oman pakistan palau panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russian federation rwanda saint helena saint lucia saint pierre and miquelon st vincent  the grenadines samoa san marino sao tome  principe saudi arabia senegal seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad  tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states of america uruguay uzbekistan vanuatu venezuela viet nam virgin islands british virgin islands us wales western sahara yemen zambia zimbabwe timorleste curacao st kitts  nevis sint maarten guernsey isle of man jersey niue montenegro your enquiry confirm purchase this market research report usd gbp euro yen inr user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  user pdf  site pdf  enterprise pdf  add to cart buy now   email report   sample report   save page   any questions   download information   check discount   download order form   email report   sample report   save page   any questions   download information   check discount   download order form contact us akash anand domain head business development saleswiseguyreportscom     us     uk rishabh arora domain head business development saleswiseguyreportscom  abu koshy domain head business development saleswiseguyreportscom     related reports × tell a friend about this report your name your email friends name friends email your enquiry send faq  heat biologics inc htbx home investors faq email alerts tear sheet ir contacts rss news feed faq what is heat biologics incs stock symbolour stock is traded on the nasdaq under the symbol htbxwhen was heat biologics inc incorporatedjune  when did heat biologics inc become a public companyjuly where is heat biologics inc located capitola drive durham nc when is heat biologics incs fiscal year enddecember stwho is heat biologics incs transfer agentcontinental stock transfer  trust company battery place th floornew york new york t who are heat biologics incs independent auditorsbdo usa llp wade park blvdsuite raleigh nc who is heat biologics incs outside legal counselgracin  marlow llp lexington avenueth floornew york ny whom can i contact for general information about heat biologics incinfoheatbiocom overview  heat biologics inc htbx home pipeline overview overview heat biologics inc htbx leading the immunooncology revolution heat’s impact immunotherapy transforms living allogeneic human cancer cells into miniature osmotic pumps that continually secrete cancer antigens to activate a patients own immune system to destroy the cancer cells learn more about our science about us heat biologics is a clinicalstage company focused on developing its proprietary “impact” immune panantigen cytotoxic therapy fully allogeneic “offtheshelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases learn more about heat biologics view our corporate presentation recent news jul   •  am edt heat biologics appoints damien hallet as vice president of cmc development read more jul   •  am edt dr jeff hutchins appointed chief operating officer for heat biologics read more events june    bio international convention learn more june    marcum microcap conference learn more impact therapy a firstinclass fully human cytotoxic t cell specific adjuvant heat biologics’ proprietary impact technology transforms allogenic living cells into miniature osmotic pumps that continually secrete heat shock protein gp the most potent mammalian adjuvant ever described along with its chaperoned antigens view our product pipeline development pipeline sign up for email alerts enter email submit